Harpoon Therapeutics, Inc. Profile Avatar - Palmy Investing

Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United…

Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of HARP's Analysis
CIK: 1708493 CUSIP: 41358P106 ISIN: US41358P2056 LEI: - UEI: -
Secondary Listings
HARP has no secondary listings inside our databases.